The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis
Open accessAbstract
BACKGROUND: Currently, there is no single-dose therapy that is effective in the treatment of urethral or endocervical infections with Chlamydia trachomatis. Azithromycin is a new azalide antibiotic that has substantial activity against C. trachomatis, is concentrated intracellularly, and has a long half-life in serum and tissue. METHODS: We conducted a trial in which 299 female patients and 158 male patients with uncomplicated genital infection and a positive C. trachomatis antigen test were randomly assigned to receive either azithromycin (1 g once orally) or doxycycline (100 mg orally twice daily for seven days). Only patients subsequently determined to have a culture positive for C. trachomatis at base line were included in the evaluation of efficacy. RESULTS: Among the patients who could be evaluated, 5 of the 141 patients (4 percent) treated with azithromycin did not respond to treatment, as compared with 3 of the 125 patients (2 percent) treated with doxycycline (difference between groups, 2 percent; 95 percent confidence interval, 0 to 6 percent). Of the patients evaluated 21 to 35 days after treatment, none of 112 treated with azithromycin and 1 of 102 treated with doxycycline had a positive culture. The rates of bacteriologic cure were similar for the 98 female patients (97 percent) and the 43 male patients (95 percent) treated with azithromycin. Seventeen percent of the patients who received azithromycin and 20 percent of those treated with doxycycline had mild-to-moderate drug-related side effects, mainly gastrointestinal symptoms. CONCLUSIONS: A single 1-g dose of azithromycin is as effective for the treatment of uncomplicated genital chlamydial infections as a standard seven-day course of doxycycline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
Compliance Declines Between Clinic Visits
Cramer, J. A. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.7.1509 · Cited by 405
Chlamydia trachomatis infections in the United States. What are they costing us?
Washington, A. E. (1987) · JAMA · doi:10.1001/jama.257.15.2070 · Cited by 231
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum.
Bowie, W. R., Wang, S. P., Alexander, E. R., Floyd, J., Forsyth, P. S., Pollock, H. M., Lin, J. S., Buchanan, T. M., & Holmes, K. K. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108694 · Cited by 211
Partial Characterization of Chlamydia trachomatis Isolates Resistant to Multiple Antibiotics
Jones, R. B., Van Der Pol, B., Martin, D. H., & Shepard, M. K. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1309 · Cited by 163
Self-citationAzithromycin in the treatment of sexually transmitted disease
Steingrı́msson, Ó., Ólafsson, J., Thórarinsson, H., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.109 · Cited by 127
Boyce, J. M., Medeiros, A. A., Papa, E. F., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.73 · Cited by 106
Siris, E. S., Clemens, T. L., Dempster, D. W., Shane, E. J., Segre, G. V., Lindsay, R., & Bilezikian, J. P. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90075-1 · Cited by 57
In-vitro activity of azithromycin against Chlamydia trachomatis
Scieux, C., Bianchi, A., Chappey, B., et al. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.7 · Cited by 45
Gynaecological tissue levels of azithromycin
Krohn, K. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975844 · Cited by 33
Cited by
Golden, M. R., Whittington, W. L. H., Handsfield, H. H., Hughes, J. P., Stamm, W. E., Hogben, M., Clark, A., Malinski, C., Helmers, J. R. L., Thomas, K. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041681 · Cited by 470
Peipert, J. F. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030542 · Cited by 383
Safety of doxycycline and minocycline: A systematic review
Smith, K., & Leyden, J. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.005 · Cited by 352
Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis.
Riedner, G., Rusizoka, M., Todd, J., Maboko, L., Hoelscher, M., Mmbando, D., Samky, E., Lyamuya, E., Mabey, D., Grosskurth, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044284 · Cited by 296
Azithromycin in control of trachoma
Schachter, J., West, S. K., Mabey, D., Dawson, C. R., Bobo, L., Bailey, R., Vitale, S., Quinn, T. C., Sheta, A., Sallam, S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12387-5 · Cited by 296
Metadata
- Authors
- Martin, D. H., Mroczkowski, T. F., Dalu, Z. A., McCarty, J., Jones, R. B., Hopkins, S. J., & Johnson, R. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-09-24
- Volume
- 327
- Issue
- 13
- Pages
- 921-925
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2337075225
- Cited by
- 264
- References
- 10
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis. https://app.cochat.ai/papers/10.1056/nejm199209243271304
- The paper
- Martin, D. H., Mroczkowski, T. F., Dalu, Z. A., McCarty, J., Jones, R. B., Hopkins, S. J., & Johnson, R. B. (1992). A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis. New England Journal of Medicine. https://doi.org/10.1056/nejm199209243271304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.